Billionaire investor confirmed through his Twitter account that he has acquired a "large position" in Allergan plc AGN.
Shares of Allergan were trading higher by more than 2.50 percent after Tuesday's opening bell. Icahn also said in a statement is he is "very supportive" of the company's CEO Brent Saunders.
Market News and Data brought to you by Benzinga APIsIcahn's investment in Allergan doesn't mark the first time he has cooperated with Saunders. Icahn helped bring in Saunders as CEO of Forest Labs and the 2 " worked cooperatively and constructively" to "increase value for all Forest shareholders." Forest was ultimately acquired by Actavis which subsequently merged with Allergan. "We have every confidence in Brent's ability to enhance value for all Allergan shareholders," Icahn's statement also read.We have recently acquired a large position in Allergan $AGN & are very supportive of CEO Brent Saunders. Read more: https://t.co/5OoDWo6Q0g
— Carl Icahn (@Carl_C_Icahn) May 31, 2016
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in